Semaglutide reduces the risk of heart attack, stroke, and other major cardiac events. | Drug Discovery And Development ...

New clinician-guided program blends medical science, microdosing, and 24/7 support to make advanced weight loss and wellness ...

A new observational study compared the risk for severe gastrointestinal adverse events across dulaglutide, semaglutide, and ...

In 2023, 48.5 million people ages 12 or older in the U.S. contended with a substance use disorder or disorders -- for almost 29 million, it was an alcohol use disorder (AUD) and around 27 million ...

Tirzepatide, semaglutide, and liraglutide vs DPP4i were associated with lower risk of alcohol use disorder, especially among men and younger patients.

The SOUL trial, published in the New England Journal of Medicine, tracked 9,650 adults with type 2 diabetes and elevated cardiovascular risk over nearly four years.

The FDA has approved Rybelsus, the first oral GLP-1 receptor agonist, to reduce cardiovascular risk in type 2 diabetes ...

Some guys are getting this promising new weight loss drug on the grey market. Here's what it does and the risks of taking it ...

A major international study led by researchers at University College London has found that semaglutide, the active ingredient ...

Semaglutide appears to safeguard the heart even when patients lose little weight. In a massive international trial, heart attack and stroke risk dropped by 20% regardless of BMI. The benefit seems ...

The cardioprotective effects of semaglutide are independent of baseline adiposity and weight loss, according to a recent study.

New research reviews show that some weight loss drugs can help people lose a lot of weight. But they also raise important ...